<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-039693</identifier>
<setSpec>1695-4033</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Adverse reaction of pseudoephedrine</dc:title>
<dc:description xml:lang="en">We present a case of a 7 years old girl who developed an episode of myoclonic movements and tremors after being medicated with a not well cuantified amount of a pseudoephedrine/antihistamine combination. We want to highlight the potencial toxicity of pseudoephedrine, usually administered as part of cold-syrup preparations which are used for symptomatic treatment of upper respiratory tract cough and congestion associated with the common cold and allergic rhinitis. Although these products are generally considered to be safe either by physicians and parents, we can&#146;t underestimate the potencial adverse events and toxic effects that can occur when administering these medications We present a case of a 7 years old girl who developed an episode of myoclonic movements and tremors after being medicated with a not well cuantified amount of a pseudoephedrine/antihistamine combination. We want to highlight the potencial toxicity of pseudoephedrine, usually administered as part of cold-syrup preparations which are used for symptomatic treatment of upper respiratory tract cough and congestion associated with the common cold and allergic rhinitis. Although these products are generally considered to be safe either by physicians and parents, we can&#146;t underestimate the potencial adverse events and toxic effects that can occur when administering these medications (AU)</dc:description>
<dc:creator>García de Frías, E</dc:creator>
<dc:creator>López Lois, G</dc:creator>
<dc:creator>Gómez Carrasco, J. A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Aportamos el caso de una niña de 7 años de edad que presentó un episodio de mioclonías y temblores de pocas horas de duración tras haber ingerido una cantidad no bien determinada de un preparado que contenía antihistamínico y seudoefedrina. Queremos destacar la potencial toxicidad de la seudoefedrina, comercializada en asociación con antihistamínicos y que se vende como fármaco para aliviar el resfriado común y la obstrucción nasal. Dichos productos se consideran medicamentos para tratar síntomas a menudo banales, por lo que pensamos que la población y, con menos frecuencia, los profesionales, pueden infravalorar la potencial toxicidad de los fármacos que los componen (AU)</dc:description>
<dc:source>An Pediatr (Barc);62(4): 378-380, abr. 2005. tab</dc:source>
<dc:identifier>ibc-039693</dc:identifier>
<dc:title xml:lang="es">Reacción adversa por seudoefedrina</dc:title>
<dc:subject>^d54899</dc:subject>
<dc:subject>^d4889^s22025</dc:subject>
<dc:subject>^d9399^s22036</dc:subject>
<dc:subject>^d14595^s22036</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2021^s22025</dc:subject>
<dc:type>article</dc:type>
<dc:date>200504</dc:date>
</metadata>
</record>
</ibecs-document>
